Today News Journal
    What's Hot

    DOJ sues Norfolk Southern over toxic train derailment in Ohio

    March 31, 2023

    Social Security funding crisis will arrive in 2033, U.S. projects

    March 31, 2023

    Richard Branson’s Virgin Orbit to lay off 85 percent of staff

    March 31, 2023
    Facebook Twitter Instagram
    Facebook Twitter Instagram
    Today News Journal
    Contact Us
    • Home
    • Trending
    • Business
    • Health
    • Technology
      • Automobile
      • Gadgets
      • Mobiles
      • Robotics
    • Lifestyle
      • Culture
    • Sports
    • Travel
    • Editorials
    • News
      • Politics
    Today News Journal
    Home » Technology » Advanced Instruments to Acquire Solentim
    Technology

    Advanced Instruments to Acquire Solentim

    James MartinBy James MartinAugust 6, 2021No Comments5 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp VKontakte Email
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Advanced Instruments, a leading manufacturer of analytical instruments and services for bioprocessing, today announced the execution of a definitive agreement to acquire Solentim, a trusted global leader of solutions for the isolation and characterization of high value single cell clones in cell line development (CLD) applications. The acquisition expands both companies’ positions in the bioprocess workflows for advanced therapies.

    Advanced Instruments’ OsmoTECH(R) portfolio of osmometers, designed specifically for the biopharm industry, are a powerful tool to characterize and optimize cell culture conditions to support clonal growth and selection as well as support upstream and downstream production processes. The Solentim products are utilized in the early stages of biologic drug development to accelerate the selection of optimal clones for production of monoclonal antibodies, gene therapies and iPSC derived cell therapies. Advanced Instruments’ and Solentim’s technologies are synergistic, drive efficiencies, and support improved clonal lines for use in therapeutic workflows.

    “The addition of Solentim aligns with our core strategy to invest in leading technologies that deliver significant customer value across different segments in monoclonal antibody and cell and gene therapies,” commented Byron Selman, President & CEO of Advanced Instruments. “The coming together of Advanced Instruments’ and Solentim’s core technologies, will be a powerful combination in support of clonal cell line development. With Solentim, we are acquiring innovative technologies that will enhance our ability to support customers in these workflows. We are also adding to our technical capabilities with the addition of imaging, advanced AI capabilities and automation expertise that will allow us to continue to expand on the innovative solutions that we deliver.”

    Solentim is based in Bournemouth, UK, with additional sites that serve customers in the United States, Europe, and Asia Pacific. This network supports the Advanced Instruments global footprint and expands our ability to support our ever-growing, combined customer base. The addition will also bring together two well-known brands with organizations that have strong commitments to their customers by providing world class scientific and customer support organizations.

    “We are excited about joining the Advanced Instruments team,” said Mark Truesdale, Chief Executive Officer of Solentim. “Our companies share many similar goals including a vision for sustained innovation, a strong connection to the customer globally and a desire to provide solutions that drive efficiency and deliver value in the development of life-sustaining therapies. The combination of our technologies and commercial footprint will support our shared vision for accelerated growth.”

    “We look forward to Solentim joining the Advanced Instruments and Patricia Industries family and continuing on the next phase of growth together,” said Yuriy Prilutskiy, Head of Patricia Industries North America, a part of Investor AB, and owner of Advanced Instruments. “Patricia Industries is committed to supporting the combined Advanced Instruments and Solentim teams in their mission to deliver solutions that accelerate and improve the development of biopharmaceuticals globally, and we are excited to accelerate investment in their combined commercial and R&D capabilities. This transaction leverages Patricia Industries’ healthcare and life sciences expertise and aligns with our purpose of creating value for people and society by building strong and sustainable businesses.”

    Advanced Instruments was represented by Rothschild & Co (financial advisor) and Simpson Thacher & Bartlett LLP (legal advisor).

    Solentim was represented by EC M&A (financial advisor) and Ernst & Young LLP (legal, financial, and tax advisor).

    For Further Information:
    Advanced Instruments
    Contact: Lisa Fahey
    781-471-2106

    Solentim
    Contact: Mark Truesdale
    +44 1202 798510

    About Advanced Instruments

    Advanced Instruments is a global provider of scientific and analytical instruments for the biotechnology, clinical, and food and beverage industries. For more than 65 years, the company’s innovations have helped organizations improve quality of results, achieve reliable outcomes, and increase workplace productivity. Advanced Instruments has a diverse portfolio of products, including freezing point osmometers, cerebrospinal fluid cell counters, anaerobic jar systems, cryoscopes, pasteurization test systems, and testing standards and controls. For more information, visit www.aicompanies.com

    About Solentim

    Solentim  is the trusted global leader in workflows for antibody and cell-based therapies. Our assurance rich technologies enable the isolation, growth and characterization of high value cells while our data driven platform enables smarter decision earlier in the process. Together, our customers experience faster workflows, confidently designed for regulatory environments.

    About Patricia Industries

    Patricia Industries, a part of Investor AB, makes control investments in best-in-class companies with strong market positions, brands and corporate cultures within industries positioned for secular growth. Our ambition is to be the sole owner of our companies, together with strong management teams and boards. We invest with an indefinite holding period and focus on building durable value and capturing organic and non-organic growth opportunities.

    About Investor AB

    Investor, founded by the Wallenberg family in 1916, is an engaged owner of high-quality, global companies. We have a long-term investment perspective. Through board participation, as well as industrial experience, our network and financial strength, we work continuously to support our companies to remain or become best-in-class. Our holdings include among others ABB, Atlas Copco, Ericsson, Molnlycke and SEB. For more information, visit www.investorab.com.

    SOURCE Advanced Instruments, LLC

    Related posts:

    1. UL Acquires Method Park
    2. LyondellBasell Achieves Industry First with Hyperzone Polyethylene Plant (KILLED)
    3. Craig Butterworth Joins Droit as Chief Commercial Officer
    4. ‘Roborace’ car makes street track debut in Marrakech
    Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    Previous ArticleReyl & Cie And 1875 Finance To Enter Into Strategic Partnership
    Next Article Allegis Capital, Leading Silicon Valley Vc, Becomes A Strategic Partner Of New Frontier Capital Management International
    James Martin
    • Website

    Related Posts

    NVIDIA’s GeForce RTX 4070 will reportedly cost $599

    March 30, 2023

    Paramount+ orders new Star Trek series set at Starfleet Academy

    March 30, 2023

    Audible is now testing ads in your audiobooks for some reason

    March 30, 2023

    Waymo’s driverless taxi fleet will soon be completely electric

    March 30, 2023

    Leave A Reply Cancel Reply

    Search
    Categories
    • Automobile
    • Business
    • Coronavirus
    • Culture
    • Editorials
    • Finance
    • Gadgets
    • Health
    • Lifestyle
    • Mobiles
    • Money
    • News
    • Politics
    • Sports
    • Technology
    • Travel
    • Trending
    • World
    Latest Posts

    DOJ sues Norfolk Southern over toxic train derailment in Ohio

    March 31, 2023

    Social Security funding crisis will arrive in 2033, U.S. projects

    March 31, 2023

    Richard Branson’s Virgin Orbit to lay off 85 percent of staff

    March 31, 2023

    Yorkshire racism allegations: Vaughan cleared, three charges against Hoggard considered proven – live | Yorkshire

    March 31, 2023
    • Facebook
    • Twitter
    Don't Miss
    News

    DOJ sues Norfolk Southern over toxic train derailment in Ohio

    By James MartinMarch 31, 20230

    Comment on this storyCommentThe Justice Department filed a major civil suit Friday against Norfolk Southern…

    Social Security funding crisis will arrive in 2033, U.S. projects

    March 31, 2023

    Richard Branson’s Virgin Orbit to lay off 85 percent of staff

    March 31, 2023

    Yorkshire racism allegations: Vaughan cleared, three charges against Hoggard considered proven – live | Yorkshire

    March 31, 2023
    • Facebook
    • Twitter
    About Us

    Hello friends, I am James Martin. Welcome to my blog todaynewsjournal.com. We are a team of experienced journalists who are passionate about delivering the latest news and current events to our readers. Our editorial team is dedicated to providing the most accurate and up-to-date information possible. We aim to be your go-to source for news and current events. Here on this site, You will get up to date information regarding all important categories like business ideas, health tips,... (Read More)

    Latest News

    DOJ sues Norfolk Southern over toxic train derailment in Ohio

    March 31, 2023

    Social Security funding crisis will arrive in 2033, U.S. projects

    March 31, 2023

    Richard Branson’s Virgin Orbit to lay off 85 percent of staff

    March 31, 2023
    SIGN UP NEWSLETTER

    Join The Conversation sign up to receive emails for The Daily special tips general info.

      Facebook Twitter Instagram Pinterest
      • Home
      • Editorials
      • Get In Touch

      Copyright © 2021-2023 · Today News Journal Privacy Policy

      Type above and press Enter to search. Press Esc to cancel.

      We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
      Cookie SettingsAccept All
      Manage consent

      Privacy Overview

      This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
      Necessary
      Always Enabled
      Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
      CookieDurationDescription
      cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
      cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
      cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
      cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
      cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
      viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
      Functional
      Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
      Performance
      Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
      Analytics
      Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
      Advertisement
      Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
      Others
      Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
      SAVE & ACCEPT

      Sign In or Register

      Welcome Back!

      Login to your account below.

      Lost password?